Rennova Health Inc (RNVA)

[nfrequent]

Revenue continues to double YOY. Sunk cost to get Myrtle Recovery to licensing (mid-August) and through to opening (November 2) put an expected pause on earnings growth. Q3 does not reflect swing bed revenue at full flow either, so another revenue surge against flat or somewhat lower costs and improving ratios to look forward to through Q4. CEO guidance for profitable 2023 holds.

Myrtle and swing bed expansion sunk costs a bit higher than I had guessed. but the revenue growth from all operations will overtake that in short order. MORE THAN $2 MILLION MORE IN DEBT REDUCTION IN Q3. Nearing $5 million so far in 2023. Solid Q3.